Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 119 of 1,261
  1. US 11976128

    Human PD-L2 antibodies and methods of use therefor

    The Board of Regents of the University of Texas System Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  2. US 11974992

    Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy

    The Regents of the University of California Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  3. US 11975035

    Methods for treating microbial infections using caudovirales bacteriophages

    The Regents of the University of California Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  4. US 11975016

    2β€²-substituted-N6-substituted purine nucleotides for RNA virus treatment

    Atea Pharmaceuticals, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  5. US 11975066

    Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof

    SAB Biotherapeutics, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  6. US 11975045

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  7. US 11975003

    Methods and compositions for treatment of Zika virus infection

    BioCryst Pharmaceuticals, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  8. US 11976293

    Optimized lentiviral vector for stem cell gene therapy of hemoglobinopathies

    The Regents of the University of California Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  9. US 11974988

    Neuroprotective compositions and methods of using the same

    The Regents of the University of California Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  10. US 11975029

    Compositions and methods for inhibition of lineage specific proteins

    Vor Biopharma Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  11. US 11976100

    Methods for treating myelin associated diseases and mitochondria associated diseases

    Larimar Therapeutics, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  12. US 11976109

    Neutralizing antibodies to ebola virus glycoprotein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  13. US 11976126

    Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

    Inhibrx, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  14. US 11975161

    Drug releasing coatings for balloon catheters

    Lutonix, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  15. US 11976098

    Cooked millet prolamin peptide for inhibiting alpha-amylase and alpha-glucosidase

    China Agricultural University Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  16. US 11976274

    Methods and compositions for identifying neoantigens for use in treating and preventing cancer

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  17. US 11975063

    Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  18. US 11975062

    Zika vaccines and immunogenic compositions, and methods of using the same

    Takeda Vaccines, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  19. US 11975056

    AADC polynucleotides for the treatment of Parkinson's disease

    VOYAGER THERAPEUTICS, INC. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  20. US 11976122

    Anti-IL13RΞ±2 antibodies

    ADC THERAPEUTICS SA Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  21. US 11975047

    Methods for storing and warming purified corticotropin compositions

    ANI Pharmaceuticals, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  22. US 11975046

    Medical use of interferon-lambda for the treatment of fibrosis

    Five Prime Therapeutics, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  23. US 11975028

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  24. US 11974989

    Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

    VTV THERAPEUTICS LLC Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.